Table 2.
BCL2-938 C > A | n | % | CC | CA | AA | df | X 2 | p-Value |
---|---|---|---|---|---|---|---|---|
Sex | ||||||||
Males | 63 | 63% | 14 | 45 | 04 | 2 | 15.96 | 0.0003 |
Females | 37 | 37% | 23 | 13 | 01 | |||
Age group in years | ||||||||
Age >45 | 44 | 44% | 10 | 30 | 4 | 2 | 8.36 | 0.015 |
Age <45 | 56 | 56% | 27 | 28 | 1 | |||
Stage of lymphoma | ||||||||
Early stage | 45 | 45% | 10 | 32 | 3 | 2 | 7.71 | 0.02 |
Advanced stage | 55 | 55% | 27 | 26 | 2 | |||
Type of lymphoma | ||||||||
Non-Hodgkin Lymphoma | 90 | 90% | 32 | 56 | 2 | 2 | 17.16 | 0.0002 |
Hodgkin Lymphoma | 10 | 10% | 5 | 2 | 3 | |||
Bone marrow involvement | ||||||||
Yes | 32 | 32% | 10 | 20 | 2 | 2 | 0.73 | 0.69 |
No | 68 | 68% | 27 | 38 | 3 | |||
MCL1- rs9803935 T > G | n | % | TT | GT | TT | df | X 2 | p -Value |
Sex | ||||||||
Males | 63 | 63% | 15 | 44 | 06 | 2 | 12.13 | 0.002 |
Females | 37 | 37% | 21 | 12 | 04 | |||
Age group in years | ||||||||
Age >45 | 44 | 44% | 22 | 16 | 6 | 2 | 9.84 | 0.007 |
Age <45 | 56 | 56% | 14 | 38 | 4 | |||
Stage of lymphoma | ||||||||
Early stage | 45 | 45% | 21 | 18 | 6 | 2 | 6.36 | 0.039 |
Advanced stage | 55 | 55% | 15 | 36 | 04 | |||
Type of lymphoma | ||||||||
Non-Hodgkin Lymphoma | 90 | 90% | 30 | 50 | 8 | 2 | 2.43 | 0.29 |
Hodgkin Lymphoma | 10 | 10% | 06 | 04 | 02 | |||
Bone marrow involvement | 36 | 54 | 10 | |||||
Yes | 32 | 32% | 10 | 18 | 4 | 2 | 0.63 | 0.72 |
No | 68 | 68% | 26 | 36 | 6 | |||
Survivin-rs17882312 G > C | n | % | TT | GT | TT | df | X 2 | p -Value |
Sex | 0.0001 | |||||||
Males | 63 | 63% | 10 | 50 | 03 | |||
Females | 37 | 37% | 21 | 15 | 01 | |||
Age group in years | ||||||||
Age >45 | 44 | 44% | 8 | 33 | 3 | 2 | 6.93 | 0.031 |
Age <45 | 56 | 56% | 23 | 32 | 1 | |||
Stage of lymphoma | ||||||||
Early stage | 45 | 45% | 10 | 31 | 04 | 2 | 7.11 | 0.028 |
Advanced stage | 55 | 55% | 21 | 34 | 0 | |||
Type of lymphoma | ||||||||
Non-Hodgkin Lymphoma | 90 | 90% | 27 | 60 | 03 | 2 | 1.67 | 0.12 |
Hodgkin Lymphoma | 10 | 10% | 04 | 05 | 01 | |||
Bone marrow involvement | ||||||||
Yes | 32 | 32% | 14 | 15 | 03 | 2 | 8.25 | 0.016 |
No | 68 | 68% | 17 | 50 | 01 | |||
Survivin-rs9904341 G > C | n | % | TT | GT | TT | df | X 2 | p -Value |
Sex | ||||||||
Males | 63 | 63% | 14 | 46 | 03 | 2 | 3.99 | 0.13 |
Females | 37 | 37% | 15 | 20 | 2 | |||
Age group in years | ||||||||
Age >45 | 44 | 44% | 07 | 35 | 02 | 2 | 6.86 | 0.032 |
Age <45 | 56 | 56% | 22 | 31 | 03 | |||
Stage of lymphoma | ||||||||
Early stage | 45 | 45% | 5 | 29 | 01 | 2 | 15.29 | 0.0004 |
Advanced stage | 55 | 55% | 24 | 27 | 04 | |||
Type of lymphoma | ||||||||
Non-Hodgkin Lymphoma | 90 | 90% | 27 | 59 | 04 | 2 | 0.89 | 0.64 |
Hodgkin Lymphoma | 10 | 10% | 2 | 7 | 1 | |||
Bone marrow involvement | ||||||||
Yes | 32 | 32% | 10 | 20 | 2 | 2 | 0.32 | 0.85 |
No | 68 | 68% | 19 | 46 | 03 |